ArticleESMO open2022

Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes.

Y Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.